Immune Escape After Adoptive T-cell Therapy for Malignant Gliomas.
Tyler J WildesKyle A DysonConnor FrancisBrandon WummerChanglin YangOleg YegorovDavid ShinAdam J GrippinBayli DiVita DeanRebecca AbrahamChristina PhamGinger L MooreCarmelle KuizonDuane A MitchellCatherine T FloresPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2020)
These findings suggest that the immune landscape of brain tumors are markedly different postimmunotherapy yet can still be targeted with immunotherapy.